# Keurig Dr Pepper Inc. (KDP) — Investment Thesis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/KDP/financials · /stocks/KDP/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/KDP/memo ($2.00, Bearer token).

## Business Model

---
source: coverage-next-full
ticker: KDP
step: 01
title: Business Model & Value Chain
retrieved: 2026-05-28
---

### Step 01 — Business Model & Value Chain

#### Key Findings

- KDP is a **brand-IP-led beverage operator with full-stack DSD distribution** in North America, generating ~$16.6B FY2025 revenue across three segments (US Refreshment Beverages ~63%, US Coffee ~27%, International ~10%) [S1][S2].
- The economic engine is **owned and licensed brand IP** (Dr Pepper, Snapple, Canada Dry, 7UP, Mott's, Keurig, GHOST, Bloom) monetized through a proprietary US **direct-store-delivery (DSD)** network — one of three large US beverage DSD networks alongside Coca-Cola and PepsiCo bottlers [S3]. This DSD network is a structural moat: it converts brand demand into retail availability without intermediary friction.
- Coffee operates a **razor + blade model** at scale: ~40M Keurig brewers seeded in US homes [S4] generate recurring K-Cup pod revenue. The hardware-pod attach economics resemble a consumables business with installed-base inertia.
- Post-JDE close (April 1, 2026), the entity becomes a **global coffee + North American beverages combo** with explicit intent to spin into two separately listed companies after integration [S5]. The value-chain map in this step describes the pre-split combined structure.

#### Implications for Thesis and Valuation

- Revenue durability is grounded in (a) Dr Pepper trademark loyalty (~80+ years), (b) Keurig brewer installed-base lock-in, (c) DSD network breadth. None require ongoing innovation to maintain baseline cash flow.
- Growth comes from three layers: (1) Dr Pepper share gains in US CSDs, (2) energy-drinks expansion via GHOST + Bloom, (3) post-JDE global coffee scale. Each has distinct unit economics that will be modeled separately downstream.
- Valuation must reflect the **announced two-company separation**: long-term steady-state value is best assessed as Refreshment Beverages Co. (stable mid-single growth, dividend payer) + Global Coffee Co. (mid-single-digit organic growth, lower-margin, more international FX exposure) rather than as a single combined entity.

#### Objective

Map KDP's business model, value-chain layers, customer economics, and revenue model. Establish the layered structure that Steps 02 (industry), 03 (revenue architecture), and 10 (moat) will refine.

#### Narrative Analysis

KDP sells branded beverages through retail (grocery, mass, club, c-store, dollar) and foodservice channels in North America, augmented by an at-home single-serve coffee ecosystem and — after April 2026 — a global packaged-coffee footprint via JDE Peet's [S1][S5].

**Core revenue model — branded beverages segment.** KDP owns or licenses brand IP (~125 brand families), produces concentrate/syrup at internal plants, packages/bottles at company-owned and contract-bottler facilities, and distributes via its proprietary DSD network and warehouse channels. The DSD model lets KDP control shelf placement, refresh frequency, and promotional execution at the store level — a meaningful operating moat in mature retail [S3]. Volume is sold to retailers at wholesale; final consumer purchase is made at retail.

**Razor + blade — coffee segment.** Keurig brewers (made at low margin, sometimes intentionally subsidized) seed the installed base; K-Cup pod sales (high margin, recurring, ~6-month consumption cycle) generate the durable cash flow. KDP estimates ~40M active brewers in US homes [S4]. Licensed brand partners (Starbucks, Dunkin', etc.) pay for K-Cup format access, providing high-margin license revenue without inventory exposure.

**Energy drinks — emerging layer.** GHOST (acquired 60% Jan 2025, remaining 40% planned 2028) plus Bloom (partnership) give KDP a position in the fastest-growing US beverage subcategory. Unit economics in energy are attractive (high gross margin, premium price points), and KDP's DSD network is the lever — GHOST struggled with distribution depth pre-acquisition [S6].

**International — Mexico-led.** Peñafiel is the #2 carbonated mineral water in Mexico; Squirt is a top brand. Canada operations distribute Dr Pepper/Snapple portfolio. Both are mature, GDP-paced markets but offer FX-translation exposure.

**Post-JDE addition — global packaged coffee.** Jacobs, Douwe Egberts, Peet's Coffee, L'OR, Tassimo, Senseo, Old Town White Coffee — predominantly European and Asian retail and foodservice channels. JDE Peet's was the global #2 packaged coffee company pre-acquisition (behind Nestlé). Brings ~€8B+ revenue, ~22%+ EBITDA margin, and distribution depth in 100+ countries [S5].

**Customer economics.** End customer (consumer) buys at retail; KDP earns the spread between input/manufacturing/distribution cost and wholesale price to retailer. The "stickiest" customer relationships are (a) Keurig brewer households (hardware lock-in), (b) Dr Pepper habit consumers (trademark loyalty), (c) commercial coffee accounts via JDE in Europe. Retailer relationships are concentrated — Walmart, Kroger, Costco, Target are top US accounts; major grocery chains are top international accounts.

#### Evidence and Sources

##### Value-Chain Layer Map

| Layer | What KDP does | Owned vs. partnered | Why it matters |
|-------|---------------|---------------------|----------------|
| Brand IP | Owns or licenses ~125 brand families | Owned (Dr Pepper, Snapple, Mott's, etc.) + licensed (Crush, Sunkist regional, Starbucks K-Cup, etc.) | Source of pricing power; ROIC depends on durable trademark equity |
| Concentrate/syrup mfg | Internal plants | Owned | Margin capture at the chemistry step |
| Bottling/packaging | Mix of owned (Pepsi-style) + contract bottlers | Mostly owned in US | Capital intensity moderate; controls cost + quality |
| DSD distribution | Proprietary US network | Owned | Structural moat; one of 3 scaled US beverage DSDs |
| Warehouse/retail logistics | Large-format retail (Walmart/Costco) via warehouse channel | Owned + 3PL | Lower-cost serve for large retailers |
| Coffee hardware | Keurig brewer design + contract mfg | Designed in-house, contract-built | Razor in the razor+blade |
| K-Cup pods | KDP-owned formats + licensed partner brands | Owned format IP + partner brand licensing | Recurring high-margin blade |
| Energy drinks | GHOST owned, Bloom partner | Mix | Growth optionality at attractive unit margins |
| International beverages | Mexico + Canada owned operations | Owned | FX-exposed but stable cash; growing |
| Global packaged coffee (post-Apr 2026) | JDE Peet's portfolio | Owned (96.22%) | Step-change scale; intent to spin |

#### Assumption Register Updates

(No new numeric assumptions in this step; structure-only. Future quantification of brand-level revenue mix will be added in Step 03.)

#### Tables and Calculations

##### Segment Revenue Split (FY2025, USD M, approximate)

| Segment | FY2025 Revenue | % of Total | Operating Margin (approx) |
|---------|----------------|------------|---------------------------|
| US Refreshment Beverages | ~10,400 | ~63% | ~28-30% (segment basis) |
| US Coffee | ~4,500 | ~27% | ~28% (lower than RB due to commodity passthrough) |
| International | ~1,700 | ~10% | ~20-22% |
| **Total** | 16,603 | 100% | n/a (consolidated incl. corporate ~21.5% reported) |

> Segment-level operating margins are approximate from public reconciliation tables; precise breakdown will be cross-checked in Step 03.

##### Revenue Model Type by Segment

| Segment | Revenue Model | Recurrence | Pricing Mechanism |
|---------|---------------|------------|---------------------|
| US Refreshment Beverages | Wholesale brand sale to retail | Habitual consumption | List + promotional + trade-spend |
| US Coffee — K-Cup pods | Recurring consumables (razor+blade blade) | Very high (installed-base inertia) | Annual list + tiered pack pricing |
| US Coffee — Brewers | Hardware one-shot | Replacement cycle ~3-5 years | Premium tiered SKU |
| International | Wholesale brand sale | Habitual + commercial | Localized list pricing |
| Global Coffee (post-Apr 2026) | Wholesale + foodservice + DTC | Habitual + commercial recurring | Mix of branded + private-label tiers |

#### Open Questions and Data Gaps

- Exact brand-level revenue (e.g., Dr Pepper alone vs. Snapple vs. Canada Dry within US RB) is not disclosed; Step 03 will use Circana category share + IR commentary to triangulate
- K-Cup attach rate per brewer (annual pods/brewer) not disclosed in detail; can be estimated from segment volume data
- JDE Peet's standalone P&L only available from JDE's pre-deal disclosures (Euronext filings through April 2026); ongoing breakdown will be at KDP's segment-reporting discretion post-Q2 2026

#### Next-Step Dependencies

Step 02 will use this value-chain layer map to assess where competitive friction is highest (concentrate mfg, DSD, brand IP) and structure the Porter five-forces analysis accordingly.

#### Source Index

| Tag | Document / URL | Section | Date | Notes |
|-----|----------------|---------|------|-------|
| [S1] | KDP 10-K FY2025 | https://www.sec.gov/Archives/edgar/data/0001418135/000141813526000016/kdp-20251231.htm | Feb 2026 | Business overview |
| [S2] | KDP XBRL summary | KDP_financials/xbrl/xbrl_summary.md | 2026-05-28 | FY2025 segment revenue |
| [S3] | KDP industry analysis | KDP_financials/industry/competitive_landscape.md | 2026-05-28 | DSD network discussion |
| [S4] | KDP Q1 2024 disclosures (40M Keurig brewers in US) | KDP investor presentation Q1 2024 + Statista 2025 | 2025 | Single-serve coffee installed base |
| [S5] | KDP 8-K April 1 2026 (JDE close) | https://news.keurigdrpepper.com/2026-04-01 | Apr 2026 | JDE Peet's acquisition close + Rafael Oliveira |
| [S6] | GHOST acquisition press release | https://news.keurigdrpepper.com/2024-10-24-Keurig-Dr-Pepper-to-Acquire-Disruptive-Energy-Drink-Business-GHOST | Oct 2024 | $990M for 60%, plus 40% in 2028 |

## Recent Catalysts

---
source: coverage-next-full
ticker: KDP
step: 12
title: Catalysts / Analyst Debate (Bull vs. Bear)
retrieved: 2026-05-28
---

### Step 12 — Catalysts / Analyst Debate

**Note:** This step adopts the `/full-research-gpt` Step 12 analyst-debate analytical framework but, since earnings-call transcripts are intentionally not loaded in the coverage-next-full path, the bull/bear positions are reconstructed from sell-side notes, KDP press releases, prepared-remarks summaries embedded in 8-Ks, and consensus aggregators rather than direct CEO/CFO color. This means nuance on forward guidance from management Q&A is not captured here.

#### Key Findings

- The 12-month KDP investment debate is dominated by **three intersecting questions**: (1) Does the **JDE Peet's integration** deliver promised cost + revenue synergies on schedule, (2) Does the **planned split into Refreshment Beverages Co. + Global Coffee Co.** create sum-of-parts value, and (3) Can **Dr Pepper continue gaining US CSD share** at 50-100bps annually [S1][S2].
- Sell-side consensus is **constructive but cautious**: Buy/Outperform = 10, Hold = 7, Sell = 0; average 12-month price target ~$35.47 vs. ~$29.30 spot = ~21% implied upside [S3]. Bulls argue the leverage spike is transitory; bears point to integration risk and the GLP-1 secular drag.
- The **biggest near-term catalyst (positive)** is the Q3 2026 earnings report — first full quarter of post-JDE consolidated results — which will set the integration credibility baseline.
- The **biggest near-term risk (negative)** is a guidance trim if synergy capture lags, which would cement the bear thesis.

#### Implications for Thesis and Valuation

- The base-case 12-month TSR scenario is ~10-15% (upside to ~$33-34 + 3.2% dividend) reflecting modest deleveraging credit and a small split-optionality bump.
- The bull-case 24-month TSR scenario is +40-50% if the split clears antitrust + JDE synergies deliver $300M+ annualized.
- The bear-case 12-month TSR scenario is -15-20% if Q3 2026 disappoints or JDE leverage burdens force dividend signaling concerns.

#### Objective

Reconstruct the canonical bull/bear analyst debate from filings + consensus + recent news; assess sentiment; identify the next 4-6 catalysts (positive and negative) that will resolve key debate questions; close with a 3+3 Bull Case / Bear Case bullet block that feeds `/complete-coverage` Step 15 and the public `/stocks` page.

#### Narrative Analysis

##### The Three Active Debates

**Debate #1 — JDE Peet's Integration: Value Creation vs. Distraction**

The dominant question. Bulls (BofA, Goldman, Jefferies in late-Feb/March 2026 notes) emphasize that KDP gains global coffee scale that closes the gap with Nestlé, that ~$200-400M cost synergies are achievable given overlapping G&A and procurement, and that the deal is structurally accretive to long-term ROIC if the split unlocks separate-multiple value. Bears (UBS, Wells Fargo, Truist) argue the deal is **strategically scattershot** — KDP is already in coffee via Keurig — and that the timing was opportunistic at JDE's distressed multiple rather than strategic. They cite the rapid leverage spike to 4.5x as a constraint on capital return, the integration execution risk for a company doing two transformational deals in 18 months (GHOST + JDE), and the absence of formal synergy targets at the closing [S4].

The neutral read: the deal is **defensible at the price paid** (12-13x estimated trailing EBITDA, reasonable for a category #2 with stable margins) but **executes on uncertain ground**. Final grade requires 2027-2028 results.

**Debate #2 — The Split Into Two Companies**

KDP's announced intent to separate into Refreshment Beverages Co. (US CSDs + DSD-distributed brands + energy) and Global Coffee Co. (Keurig + JDE Peet's combined) is a **sum-of-parts unlock thesis**. Bulls model: Refreshment Beverages Co. at 16-18x EBITDA (similar to KO/PEP standalone CSD optionality), Global Coffee Co. at 12-14x EBITDA (Nestlé Health Science + Lavazza comps). Combined SOP = ~$33-37/share, vs. current ~$29-30. Implied upside ~15-25% if split executes by 2028.

Bears point to (a) execution risk — no formal timetable; (b) potential antitrust modifications to the JDE-acquired assets; (c) the dis-synergy of separating shared services, IT, procurement, marketing infrastructure. Wells Fargo's Feb 2026 note estimates ~$150-200M one-time separation costs and ~$50-75M annual dis-synergies post-split [S5].

The neutral read: the **option value is real and underpriced**, but it is option value — investors must accept multi-year holding and uncertain timing.

**Debate #3 — Dr Pepper Share Gain Durability**

Dr Pepper has reportedly become the #2 CSD trademark in the US (overtaking Pepsi in some Nielsen/Circana cuts) by mid-2025, with reported share gains of 50-100bps annually since 2022 [S6]. Bulls argue this is structural — the brand has a unique flavor profile, marketing has been highly effective ("Fansville" campaign), and the trade has rewarded Dr Pepper with shelf gains. Bears argue this is mean-reversion-prone — Pepsi has structurally responded with category-management investments and pricing flexibility — and that share gains decelerate once the trademark reaches saturation in heavy-CSD geographies.

The neutral read: **continued share gain at 50-100bps annually is achievable through 2026-2027** but the gain rate **decelerates as the brand approaches structural ceiling** (likely 12-13% US CSD trademark share).

##### Consensus Snapshot (as of late May 2026)

| Metric | Value | Source |
|--------|-------|--------|
| Coverage | 17 analysts | [S3] |
| Buy / Outperform | 10 | [S3] |
| Hold | 7 | [S3] |
| Sell | 0 | [S3] |
| 12-month avg PT | $35.47 | [S3] |
| 12-month PT range | $24-42 | [S3] |
| Current price (May 2026) | ~$29.30 | [S3] |
| Implied upside | ~21% to mean PT | [S3] |
| FY2026E adj EPS | ~$2.05 | [S3] |
| FY2027E adj EPS | ~$2.55 | [S3] |
| FY2027E revenue (combined) | ~$40.9B | [S3] |
| Current fwd P/E | ~14.3x FY2026E | Derived |

##### Catalyst Calendar (next 18 months)

| Date | Catalyst | Direction | Why It Matters |
|------|----------|-----------|----------------|
| Late July 2026 | Q2 2026 earnings (last standalone-KDP quarter ex JDE) | Neutral | Bridge to pre-/post-deal comparison; integration prep update |
| Late October 2026 | Q3 2026 earnings (first full post-JDE consolidated quarter) | **High-stakes** | Synergy run-rate, organic-growth quality, leverage trajectory all crystallize |
| Late Feb 2027 | FY 2026 + Q4 2026 release; FY 2027 guidance | High | First combined-entity full-year framework |
| Q1-Q2 2027 | Formal synergy target disclosure (expected timing) | High | Markets need to peg synergy capture to ROIC |
| Mid-2027 | Antitrust / regulatory milestone updates on the split | Medium | Removes split-timing tail risk |
| Late 2027 | Net leverage progress to ~4.0x | Medium | Validates deleveraging glide path |
| 2028 | Split timeline announcement; possible Form 10 filings | High | Unlocks SOP optionality |

##### Recent News Flow (last 90 days)

- **April 23, 2026:** Q1 2026 earnings — reaffirmed FY 2026 guidance of low-DD net sales + adj EPS growth; commentary positive on Dr Pepper share, US Coffee stable, GHOST contributing 6+ pp [S7]
- **April 1, 2026:** JDE Peet's deal closed — leadership announcements (Rafael Oliveira to lead Global Coffee Co.; Tim Cofer to lead Refreshment Beverages Co.) [S2]
- **March 10, 2026:** Equity offering completed — 130M shares at $26.50 = $3.45B [S8]
- **February 23, 2026:** Financing transactions detailed in 8-K — $4.5B convertible preferred (Apollo/KKR), $9B new term debt [S1]
- **February 24, 2026:** Q4 2025 earnings release — initial FY 2026 guide given; reaffirmed at Q1 2026 [S9]

##### Sell-Side Sentiment Detail

- **Bulls (avg PT ~$38-42):** BofA ($42), Goldman ($40), Jefferies ($38), Morgan Stanley ($39). Thesis: JDE creates global coffee #2; split unlocks SOP; Dr Pepper compounds share; energy via GHOST scales; deleveraging credit by end-2027.
- **Holds (avg PT ~$32-35):** UBS ($32), Wells Fargo ($34), Truist ($33), Citi ($35). Thesis: Deal-execution uncertainty + leverage drag + GLP-1 long-term overhang offset operational momentum.
- **No active Sell ratings as of May 2026.**

##### Variant Analyst Views (Worth Highlighting)

- **Goldman** flags KDP as a "core long-duration compounder" trading at a discount to KO/PEP not justified by 2028 normalized economics [S3].
- **UBS** flags the convertible preferred as **the most under-discussed risk** — sponsor dilution at conversion could meaningfully reset share count [S3].
- **Wells Fargo** estimates ~$150-200M one-time separation costs and ~$50-75M annual dis-synergies on the split [S5].

#### Assumption Register Updates

- A24: 12-month PT (consensus mean): $35.47 — Type: Fact
- A25: Spread to bull PT: ~$42 = ~43% upside — Type: Fact
- A26: Spread to bear PT: ~$24 = ~18% downside — Type: Fact
- A27: Implied probability-weighted 12mo return (consensus-weighted): ~12-15% — Type: Estimate

#### Tables and Calculations

##### Bull / Bear / Neutral Probability Weights (filings + consensus derived)

| Outcome | Weight | Catalysts |
|---------|--------|-----------|
| Bull | 30% | JDE synergies > $400M; split clears <12mo; Dr Pepper gains 100bps+ annually; deleveraging on schedule |
| Base | 45% | JDE synergies $200-300M; split executes 2028; share gains continue at 50-75bps; gradual deleveraging |
| Bear | 25% | Synergies <$150M; split delayed > 24mo; GLP-1 drag bites Dr Pepper Zero Sugar; leverage stays elevated |

##### 24-Month Implied Returns by Scenario

| Scenario | EOP Price | TSR (incl div) | Probability | EV |
|----------|-----------|----------------|-------------|-----|
| Bull | ~$42 | +50% | 30% | +15.0pp |
| Base | ~$33 | +18% | 45% | +8.1pp |
| Bear | ~$24 | -14% | 25% | -3.5pp |
| **Weighted EV** | | | | **~+19.6%** |

> The 24-month probability-weighted return is materially above the 12-month consensus PT-implied return (~21%) because the split optionality lengthens the realization horizon.

#### Open Questions and Data Gaps

- Apollo/KKR convertible preferred conversion price — not in public filings; matters for diluted share count
- Formal synergy quantification — KDP has not publicly committed to a $-target
- Split timeline — explicit Form-10 filing date is the key data point still missing
- Q2 2026 print (late July) is the next material data injection

#### Next-Step Dependencies

Step 13 (`/complete-coverage` forecast) builds explicit revenue/margin/EPS forecasts using the assumption register above. Step 15 scenarios formalize the 30/45/25 probability weights. Step 16 (Variant) examines what the market is mispricing vs. consensus.

#### Source Index

| Tag | Document / URL | Section | Date | Notes |
|-----|----------------|---------|------|-------|
| [S1] | KDP 8-K — JDE financing transactions | $4.5B convertible preferred + $9B term debt | Feb 23, 2026 | Cap structure |
| [S2] | KDP 8-K — JDE close announcement | Leadership + structure | Apr 1, 2026 | Closing terms |
| [S3] | KDP_financials/other/consensus.md | Analyst coverage + PT distribution | May 2026 | Aggregator-sourced |
| [S4] | UBS / Wells Fargo / Truist notes | KDP rating + thesis | Feb-Apr 2026 | Hold-rating bear theses |
| [S5] | Wells Fargo Feb 2026 note | Split cost estimate | Feb 2026 | $150-200M one-time + dis-synergies |
| [S6] | KDP Q4 2025 + Q1 2026 PRs | Dr Pepper share gain commentary | Feb-Apr 2026 | #2 CSD trademark |
| [S7] | KDP Q1 2026 earnings PR | GHOST contribution + segment commentary | Apr 23, 2026 | GHOST 6+ pp |
| [S8] | KDP 8-K equity offering | 130M shares at $26.50 | Mar 10, 2026 | $3.45B equity raise |
| [S9] | KDP Q4 2025 earnings PR | FY 2026 guidance | Feb 24, 2026 | Low-DD growth guide |

---

#### Bull Case — 3 bullets

1. **JDE Peet's integration delivers $300M+ run-rate synergies + Refreshment Beverages Co. + Global Coffee Co. split successfully executes by 2028** — sum-of-parts implies ~$33-37/share equity value, ~15-25% upside from current ~$29.30 with the split unlocking previously-discounted coffee economics at coffee-pure-play multiples (Nestlé Health Science / Lavazza comp set).
2. **Dr Pepper sustains 50-100bps annual US CSD trademark share gains through 2026-2027** — combined with disciplined pricing (mid-single-digit net realized rev / case via Zero Sugar mix + premiumization), the brand alone could contribute 200-300bps of organic growth, providing a defensible compounder profile even before GHOST/Bloom scaling.
3. **GHOST + Bloom scale to $1B+ combined energy revenue by 2028** — KDP's DSD network turns under-distributed cult brands into national distribution; energy/wellness becomes a 10%+ revenue segment with double-digit organic growth, structurally diversifying the portfolio away from CSD GLP-1 risk.

#### Bear Case — 3 bullets

1. **JDE Peet's integration disappoints — synergies <$150M, split delayed past 2028, or dis-synergies higher than modeled** — leverage stays elevated at >4x net debt/EBITDA through 2027, dividends grow at single-digits not double-digits, and the equity multiple compresses to ~11-12x adj EPS (vs. KO/PEP at ~22-25x).
2. **GLP-1 secular demand erosion accelerates beyond mitigation pace** — US household penetration of semaglutide/tirzepatide hits 25%+ by 2028 (vs. 12-15% in 2026), driving 1.5-2.0pp annual CSD volume drag that Zero Sugar/Bloom upside can only partially offset; results miss consensus organic growth by 100-200bps annually 2027-2028.
3. **Apollo/KKR convertible preferred dilution surprises** — sponsors exit at conversion in 2027-2028 adding 7-9% to diluted share count, simultaneously a Mondelez residual stake sell-down pressures price; combined cap-structure overhang produces a 12-month price drag of 10-15% even before fundamental concerns crystallize.

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/KDP/memo

## Navigation

- Overview: /stocks/KDP
- Financials: /stocks/KDP/financials
- Thesis (this page): /stocks/KDP/thesis
- Investment Memo: /stocks/KDP/memo
- Coverage universe: /stocks